MassMutual Private Wealth & Trust
PCRX icon

MassMutual Private Wealth & Trust’s Pacira BioSciences PCRX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.69K Sell
307
-28
-8% -$709 ﹤0.01% 1441
2026
Q2 		$8.5K Hold
335
– – ﹤0.01% 1471
2026
Q1 		$7.57K Buy
335
+24
+8% +$533 ﹤0.01% 1492
2025
Q4 		$8.05K Buy
311
+28
+10% +$666 ﹤0.01% 1482
2025
Q3 		$7.29K Sell
283
-118
-29% -$2.9K ﹤0.01% 1525
2025
Q2 		$9.6K Buy
401
+68
+20% +$1.71K ﹤0.01% 1377
2025
Q1 		$8.28K Buy
333
+288
+640% +$6.9K ﹤0.01% 1372
2024
Q4 		$848 Hold
45
– – ﹤0.01% 2054
2024
Q3 		$677 Sell
45
-165
-79% -$2.82K ﹤0.01% 1933
2024
Q2 		$6.01K Sell
210
-93
-31% -$2.65K ﹤0.01% 1254
2024
Q1 		$8.85K Buy
303
+15
+5% +$461 ﹤0.01% 1078
2023
Q4 		$9.7K Buy
288
+254
+747% +$7.43K ﹤0.01% 1031
2023
Q3 		$1.04K Sell
34
-88
-72% -$3.17K ﹤0.01% 1679
2023
Q2 		$4.89K Buy
122
+16
+15% +$661 ﹤0.01% 1220
2023
Q1 		$4.33K Buy
106
+3
+3% +$119 ﹤0.01% 1186
2022
Q4 		$4K Buy
103
+66
+178% +$3.21K ﹤0.01% 1091
2022
Q3 		$2K Buy
37
+3
+9% +$167 ﹤0.01% 1263
2022
Q2 		$2K Sell
34
-6
-15% -$393 ﹤0.01% 1177
2022
Q1 		$3K Buy
40
+29
+264% +$1.93K ﹤0.01% 1073
2021
Q4 		$1K Buy
+11
New +$607 ﹤0.01% 1279
2017
Q4 		– Sell
-5,736
Closed -$215K – 960
2017
Q3 		$215K Buy
5,736
+258
+5% +$10.4K 0.02% 343
2017
Q2 		$261K Sell
5,478
-141
-3% -$6.54K 0.02% 307
2017
Q1 		$256K Buy
+5,619
New +$243K 0.02% 310

Other funds holding PCRX

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Gagnon Securities
Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bridge City Capital
Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return
GA
Gagnon Advisors New York $182M AUM 52.04% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

MassMutual Private Wealth & Trust's PCRX Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its Pacira BioSciences (PCRX) stake by 8.4% in Q3 2026, selling an estimated $709 and leaving 307 shares worth $7.69K. The position accounts for ﹤0.01% of the portfolio, ranked #1441.

MassMutual Private Wealth & Trust first reported a position in PCRX in Q1 2017 and has held it in 23 quarters since. The position peaked at $261K in Q2 2017. 107 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

  • MassMutual Private Wealth & Trust held 307 shares of Pacira BioSciences worth $7.69K as of Q3 2026.
  • MassMutual Private Wealth & Trust sold 28 Pacira BioSciences shares in Q3 2026, an estimated $709.
  • Pacira BioSciences made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1441 holding.
  • MassMutual Private Wealth & Trust first reported a position in Pacira BioSciences in Q1 2017 and has held it in 23 quarters since.
  • MassMutual Private Wealth & Trust's Pacira BioSciences position peaked at $261K in Q2 2017.
  • 107 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.